Document is current
Any future updates will be listed below
-
Authors
Loubert, Angély
Creel, Kristin
Bhandari, Naleen Raj
Hess, Lisa M.
Ruppert, Amy S.
Abada, Paolo
Regnault, Antoine
Payakachat, Nalin
-
Funding
Funding for this research was provided by:
Eli Lilly and Company (Eli Lilly and Company)
- License Information
-
More Information
Article History
Received: 9 September 2025
Accepted: 9 June 2026
First Online: 22 June 2026
Declarations
:
: The protocols were approved by the institutional review boards or independent ethics committees overseeing each site. The studies were done in compliance with the Declaration of Helsinki, Good Clinical Practice guidelines, and local laws. All patients provided written informed consent. The studies were registered on (BRUIN-CLL-321 identifier; NCT04666038, BRUIN-MCL-321 identifier; NCT04662255).
: Not applicable.
: K.C., A.R, and A.L., declares employment with Modus Outcomes, and a service contract with Eli Lilly. N.R.B., A.S.R., L.M.H., P.A., and N.P. declares employment with Eli Lilly and Company with minor stock options.
